Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing – Genetically modified micro-organism – cell – or virus
Reexamination Certificate
2006-08-22
2006-08-22
Crouch, Deborah (Department: 1632)
Drug, bio-affecting and body treating compositions
Whole live micro-organism, cell, or virus containing
Genetically modified micro-organism, cell, or virus
C424S093200, C435S320100, C435S455000
Reexamination Certificate
active
07094400
ABSTRACT:
The present invention provides a method of altering the concentration or level of expression of a desired gene product in a recipient subject which involves administering to a recipient a transkaryotic cell capable of expressing a desired gene when the cell is present within the subject. The invention further pertains to compounds produced by such cells, by transkaryotic animals in response to such cells, and to the uses of such compounds.
REFERENCES:
patent: RE30059 (1979-07-01), Lindstrom
patent: 4332893 (1982-06-01), Rosenberg
patent: 4497796 (1985-02-01), Salser et al.
patent: 4621050 (1986-11-01), Sugimoto
patent: 4621053 (1986-11-01), Sugimoto
patent: 4897355 (1990-01-01), Eppstein et al.
patent: 4946787 (1990-08-01), Eppstein et al.
patent: 5049386 (1991-09-01), Eppstein et al.
patent: 5208036 (1993-05-01), Eppstein et al.
patent: 5366737 (1994-11-01), Eppstein et al.
patent: 5622712 (1997-04-01), Eppstein et al.
patent: 5994127 (1999-11-01), Selden
patent: 6048524 (2000-04-01), Selden
patent: 6048729 (2000-04-01), Selden
patent: 6054288 (2000-04-01), Selden
patent: 6187305 (2001-02-01), Treco
patent: 6303379 (2001-10-01), Selden
patent: 6355241 (2002-03-01), Selden
patent: 0 161 640 (1985-11-01), None
Baker et al., 1982, in: Fourth Edition, The Study of Biology, Addison-Wesley Publishing Co., Menlo Park, CA, p. 922.
Cline, 1987, Am. J. Med. 83, 291-297.
Selden et al., 1987, New Eng. J. Med. 317(17), 1067-1076.
Goding, 1983, in: Monoclonal Antibodies: Principles and Practice, Academic Press, London, pp. 87-88.
Williams et al., 1984, Nature 310, 476-480.
Miller et al., 1984, Science 225, 630-632.
Anderson, 1984, Science 226, 401-408.
Sevier et al., 1981, Clinical Chemistry 27(11), 1797-1806.
Crystal, 1995, Science 270, 404-410.
Robinson, C., 1993, TIBTECH 11, 155.
Orkin et al., Dec. 7, 1995, “Report and Recommendations of the Panel to Assess the NIH Investment in Research on Gene Therapy”.
Selden et al., (1986) Molec. Cell. Biol. 6(9): 3173-3179.
Vieira et al., (1981) Gene 19: 259-268.
Lindahl et al. Cellular Aspects of Gene Therapy. Growth Factors in Health and Disease. Elsevier Science Publishers B.V. (Biomedical Division, Westermark, C. et al. eds. 1990, pp. 383-392.
Greenhalgh et al. Epidermis: An Attractive Target Tissue For Gene Therapy. Journal Invest. Dermatol. 1994, Bol. 103, pp. 63S-69S.
Ghazizadeh et al. Virus-Mediated Gene Transfer for Cutaneous Gene Therapy. Human Gene Therapy. Nov. 1, 2000, vol. 11, pp. 2247-2251.
Mulligan R. The Basic Science of Gene Therapy. Science. May 14, 1993, vol. 260, pp. 926-932.
Crouch Deborah
Shire Human Genetic Therapies, Inc.
Wolf Greenfield & Sacks P.C.
LandOfFree
Transkaryotic implantation does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Transkaryotic implantation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Transkaryotic implantation will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3635436